Skyview Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Skyview Financial Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.28M	Buy	+5,657	New	+$3.2M	3.38%	10

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Skyview Financial Group's TMO Position: Q4 2025 in Review

Skyview Financial Group opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 5,657 shares worth $3.28M. The stake represents 3.38% of the portfolio and ranks #10 among its holdings.

2,703 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Skyview Financial Group held 5,657 shares of Thermo Fisher Scientific worth $3.28M as of Q4 2025.
Thermo Fisher Scientific was a new Skyview Financial Group position in Q4 2025.
Thermo Fisher Scientific made up 3.38% of Skyview Financial Group's portfolio in Q4 2025, its #10 holding.
2,703 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Skyview Financial Group's 13F filing for Q4 2025, filed 18 Feb 2026.